project id: TCGA-CESC; case submitter id: TCGA-EK-A2RA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.8; age at index: 74; days to birth: -27209; ethnicity: hispanic or latino; gender: female; race: not reported; vital status: Alive; year of birth: 1937; age at diagnosis: 27209; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T2a2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1246.0; figo stage: Stage IIA2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 232; initial weight: 130.0; oct embedded: false; preservation method: Unknown; sample id: cf39d26f-ae75-40ee-a809-3f48e2558e54; sample submitter id: TCGA-EK-A2RA-01A; portion id: 82453af1-579d-4e1b-af1e-593a50290680; portion submitter id: TCGA-EK-A2RA-01A-11; slide id: 81460008-abf6-4d9f-87a9-6f85a4d310c3; slide submitter id: TCGA-EK-A2RA-01A-01-TS1; percent lymphocyte infiltration: 25.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 22.0; percent tumor cells: 60.0; percent tumor nuclei: 65.0; section location: TOP;